Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Nutrition Company (INC) is a specialized nutraceutical and biotechnology firm primarily known for its ownership and development of Pycnogenol, a standardized extract of French maritime pine bark. The company focuses on the research, development, and global distribution of high-quality botanical ingredients backed by extensive clinical evidence. INC operates in close partnership with Horphag Research, which serves as the exclusive worldwide distributor and research coordinator for their flagship products. Their business model centers on licensing their proprietary extracts to manufacturers of dietary supplements, functional foods, and cosmetic products. With over 40 years of research, the company's portfolio is supported by hundreds of scientific publications and clinical trials across various therapeutic areas including cardiovascular health, joint support, and cognitive function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Nutrition Company.